Clinical outcomes and safety of tocilizumab in severe fever with thrombocytopenia syndrome: a retrospective multicenter cohort study.
- DOI
- 10.3389/fcimb.2026.1894849
- Published
- 2026
- Container
- Frontiers in cellular and infection microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcimb.2026.1894849,
title = {Clinical outcomes and safety of tocilizumab in severe fever with thrombocytopenia syndrome: a retrospective multicenter cohort study.},
author = {Hu Q and Jin Y and Wei Y and Chen J and Hu Y and Yang Y and Zhang L and Chen S and Duan G},
year = {2026},
journal = {Frontiers in cellular and infection microbiology},
doi = {10.3389/fcimb.2026.1894849},
url = {https://doi.org/10.3389/fcimb.2026.1894849}
}RIS
TY - JOUR TI - Clinical outcomes and safety of tocilizumab in severe fever with thrombocytopenia syndrome: a retrospective multicenter cohort study. AU - Hu Q AU - Jin Y AU - Wei Y AU - Chen J AU - Hu Y AU - Yang Y AU - Zhang L AU - Chen S AU - Duan G PY - 2026 JO - Frontiers in cellular and infection microbiology DO - 10.3389/fcimb.2026.1894849 UR - https://doi.org/10.3389/fcimb.2026.1894849 ER -
APA
Q, H., Y, J., Y, W., J, C., Y, H., Y, Y., L, Z., S, C., & G, D. (2026). Clinical outcomes and safety of tocilizumab in severe fever with thrombocytopenia syndrome: a retrospective multicenter cohort study.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1894849
Source records
- pubmed · retrieved 2026-09-25T03:31:59.765Z